Loading…
Ravelcare (BSE 544629)₹90.00−3.23%Personal Care
In the Mar 2026 quarter (standalone), Ravelcare reported sales of ₹12.52 Cr, down 13.9% from Mar 2025, and net profit of ₹1.94 Cr, up 30.2% year on year. For the year to Mar 2026, sales were ₹26.87 Cr and net profit ₹5.14 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 14.54 | 12.52 |
| Expenses | 13.32 | 9.85 |
| Operating Profit | 1.29 | 2.73 |
| OPM % | 8.8% | 21.7% |
| Other Income | 0.28 | 0.05 |
| Interest | 0.00 | 0.00 |
| Depreciation | 0.04 | 0.02 |
| Profit before tax | 1.49 | 2.72 |
| Tax % | 0.7% | 28.5% |
| Net Profit | 1.49 | 1.94 |
| EPS (Rs) | 2.99 | 2.83 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | — | 0.78 | 3.47 | 21.99 | 24.91 | 26.87 |
| Expenses | — | 1.01 | 2.98 | 15.36 | 18.15 | 19.91 |
| Operating Profit | — | −0.22 | 0.52 | 6.72 | 6.86 | 7.08 |
| OPM % | — | −26.6% | 14.7% | 30.5% | 27.5% | 26.2% |
| Other Income | — | 0.00 | 0.00 | 0.20 | 0.33 | 0.09 |
| Interest | 0.00 | 0.00 | 0.00 | 0.06 | 0.03 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.01 | 0.09 | 0.06 |
| Profit before tax | −0.10 | −0.21 | 0.50 | 6.80 | 7.01 | 7.05 |
| Tax % | 0.0% | 0.0% | −11.8% | 25.0% | 25.4% | 26.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Net Profit | −0.10 | −0.22 | 0.55 | 5.09 | 5.24 | 5.14 |
| EPS (Rs) | −219.42 | −458.72 | 1,116.33 | 10,173.19 | 10.46 | 7.49 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 0.00 | 0.02 | 0.02 | 5.00 | 6.84 |
| Reserves | −0.11 | −0.34 | 0.15 | 5.25 | 5.32 | 30.45 |
| Borrowings | 0.11 | 0.41 | 0.40 | 0.03 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | −0.01 | 1.18 | 4.16 | 2.59 | 0.22 |
| Total Liabilities | 0.00 | 0.06 | 1.75 | 9.46 | 12.91 | 37.51 |
| Fixed Assets | 0.00 | 0.00 | 0.02 | 0.23 | 0.17 | 0.10 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.47 |
| Investments | 0.00 | 0.00 | 0.00 | 0.78 | 3.06 | 4.50 |
| Other Assets | 0.00 | 0.06 | 1.73 | 8.45 | 9.68 | 30.44 |
| Inventories | 0.00 | 0.00 | 0.65 | 0.44 | 1.48 | 1.53 |
| Trade receivables | 0.00 | 0.00 | 0.00 | 0.16 | 2.47 | 7.10 |
| Cash & equivalents | 0.02 | 0.02 | 0.99 | 0.13 | 0.71 | 1.03 |
| Total Assets | 0.00 | 0.06 | 1.75 | 9.46 | 12.91 | 37.51 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | −0.40 | 0.99 | 6.48 | −0.54 | −17.46 |
| Cash from investing activity | 0.00 | 0.00 | −6.89 | 1.17 | −4.11 |
| Cash from financing activity | 0.40 | 0.00 | −0.43 | −0.03 | 21.88 |
| Net cash flow | 0.00 | 0.99 | −0.88 | 0.58 | 0.33 |
| Capex | 0.00 | 0.02 | 0.24 | 0.05 | 2.51 |
| Free cash flow | −0.40 | 0.98 | 6.24 | −0.58 | −19.92 |
| CFO / OP % | 195.0% | 196.0% | 122.0% | 17.0% | −231.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 0 | 0 | 3 | 36 | 96 |
| Inventory days | 0 | 307 | 24 | 104 | 90 |
| Days payable | — | 150 | 74 | 22 | 43 |
| Cash conversion cycle | 0 | 158 | −46 | 119 | 145 |
| Working capital days | −166 | −87 | −32 | 50 | 118 |
| ROCE % | −466.8% | 154.5% | 233.9% | 89.6% | 29.6% |
For the Mar 2026 quarter, Ravelcare reported sales of ₹12.52 Cr, down 13.9% year on year and net profit of ₹1.94 Cr, up 30.2% year on year. The operating margin was 21.7%.
Ravelcare's sales for the year to Mar 2026 were ₹26.87 Cr.
Net profit for the year to Mar 2026 was ₹5.14 Cr. Earnings per share over the same trailing period were ₹7.49.
Ravelcare reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹1.03 Cr.
Cash from operations was −₹17.46 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹19.92 Cr.